Methylated Alteration of SHP1 Complements Mutation of JAK2 Tyrosine Kinase in Patients with Myeloproliferative NeoplasmJunjun Yang(Wenzhou Medical University), Shenmeng Gao(Wenzhou Medical University)Asian Pacific Journal of Cancer PreventionApril 3, 201510.7314/apjcp.2015.16.6.2219Cited by 12SaveCiteExport RISWatch citationsRelated PapersHistone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms|Experimental Hematology|2012|87A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia|BMC Cancer|2018|75